Authors
Latest:
Parkinson's Disease: Deep Brain StimulationThe intractable, neurodegenerative movement disorder Parkinson's disease has challenged clinicians since its identification in 1817.
Latest:
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.
Latest:
Acute Pain: Considerations in Geriatric PatientsAcute pain is the body's normal response to noxious stimuli.
Latest:
Lasmiditan For the Acute Treatment of Migraine: An Opportunity For PharmacistsDespite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
Pharmacist Technicians Can Play Key Role in Push Toward Telemedicine During COVID-19 PandemicLessons from implementing electronic medical records should be heeded by allowing clinicians to focus on patient care and by delegating the management of telemedicine to support staff, such as pharmacy technicians.
Latest:
Point-of-Care Testing Offers New OpportunitiesConsider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
Latest:
Contributions of Pharmacists in the Treatment of Epilepsy: A Systematic ReviewThe treatment of epilepsy is complex and can cause drug-related problems and hamper quality of life. Clinical services performed by pharmacists may optimize the pharmacotherapy and avoid or mitigate these problems.
Latest:
Cannabidiol Presents ConundrumsRecent federal legalization and increases sales of CBD underscore the importance of considering its pharmacologic impact.
Latest:
Vaccines Play a Role in Cancer TreatmentThere Is Room for Improvement in Treating Malignancies Caused by Infectious Agents, Especially Considering the Cost Differential
Latest:
Management of Long-Term Cancer Care CostsOral cancer treatments provide new opportunities for improved overall survival rates, but patients are increasingly responsible for higher out-of-pocket costs as they self-manage their therapy.
Latest:
Pilot Study in Drug Shortages Evaluates Oncology Patient Awareness, Management PreferencesOncology drugs have especially fallen victim to chronic shortages, consequently affecting the availability of substitute agents.
Latest:
Specialty Pharmacy Today: Improving the Lives of Patients With Rare Diseases Through Orphan Drug ManagementThe specialty pharmacy marketplace has quickly become the primary dispenser of most therapies for orphan conditions.
Latest:
Budget Impact of Everolimus in Treating Metastatic Renal Cell CarcinomaA decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Latest:
Unique Considerations for Specialized Patient Populations for Pharmacies Utilizing Appointment-Based Care Models: Part 2While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.
Latest:
Fighting Free Radicals: Do You Need Antioxidants?Patients may have questions about taking antioxidants.
Latest:
Cost-Effectiveness of Rasagiline Compared With First-Line Early Parkinson Disease TherapiesExamination of the cost-effectiveness of rasagiline versus other approved first-line Parkinson disease therapies indicated that rasagiline was either cost saving or cost-effective in all cases.
Latest:
Challenges of Channel Management for Specialty: Medical Benefit or Pharmacy BenefitRegardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.
Latest:
Do Statins Interfere With Clopidogrel During Platelet Therapy?Despite data that might suggest a drug interaction, clinical significance is the deciding factor when considering therapeutic benefit over risk.
Latest:
Health Information Technology: Facilitating an Evolution in Health CareThe use of health information technology empowers pharmacists to provide enhanced care by harnessing a wealth of actionable information.
Latest:
A Closer Look at New FDA Actions: Amgen's ProliaAmgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.
Latest:
An Intermittent Reinforcement Platform to Increase Adherence to MedicationsAn automated reinforcement platform was shown to increase statin adherence by 34.6%.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
Introduction to the Hospital-Acquired Condition Reduction Program for PharmacyThis manuscript addresses pharmacist understanding of and/or involvement with the Hospital-Acquired Condition Reduction Program (HACRP) at their institutions.
